Arbutus Biopharma Corp (ABUS)

Sentiment-Signal

14,6
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
8.4
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destabilize HBV RNA, which leads in the reduction of HBsAg and other viral proteins; AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune response; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has strategic alliance, licensing, and research collaboration agreements with Talon Therapeutics, Inc.; Gritstone Oncology, Inc.; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd.; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Vaccitech plc to evaluate a triple combination of AB-729 for the treatment of chronic HBV infection. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.

Unternehmen & Branche

NameArbutus Biopharma Corp
TickerABUS
CIK0001447028
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP03879J100
ISINUS03879J1007
TypCommon Stock
Marktkapitalisierung809,4 Mio. USD
Beta0,74
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K14,083,000-33,501,000-0.1794,618,00076,576,000
2025-09-3010-Q529,000-7,742,000-0.0497,710,00077,399,000
2025-06-3010-Q10,739,0002,523,0000.01103,267,00082,976,000
2025-03-3110-Q1,764,000-24,526,000-0.13117,010,00079,157,000
2024-12-3110-K6,171,000-69,920,000-0.38131,707,00097,366,000
2024-09-3010-Q1,339,000-19,717,000-0.10140,441,000106,890,000
2024-06-3010-Q1,726,000-19,796,000-0.11160,043,000122,454,000
2024-03-3110-Q1,532,000-17,875,000-0.10150,290,000114,637,000
2023-12-3110-K18,141,000-72,849,000-0.44144,401,000106,018,000
2023-09-3010-Q4,658,000-20,104,000-0.12158,641,000119,337,000
2023-06-3010-Q4,651,000-17,094,000-0.10176,823,000134,693,000
2023-03-3110-Q6,687,000-16,339,000-0.10191,224,000143,915,000
2022-12-3110-K39,019,000-69,456,000-0.46195,419,000136,852,000
2022-09-3010-Q5,952,000-17,567,000-0.12203,801,000145,517,000
2022-06-3010-Q14,241,000-14,192,000-0.10215,836,000153,142,000
2022-03-3110-Q12,581,000-15,765,000-0.11236,877,000165,845,000
2021-12-3110-K10,988,000-76,247,000-0.83204,485,000169,439,000
2021-09-3010-Q3,340,000-19,158,000-0.24165,596,000130,140,000
2021-06-3010-Q2,329,000-19,387,000-0.23135,376,000100,829,000
2021-03-3110-Q2,113,000-16,381,000-0.21146,240,000114,149,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
MORGAN STANLEY26,702,776026,702,776128,440,353Neu+100,0%
BlackRock, Inc.13,052,861013,052,86162,784,261Neu+100,0%
VANGUARD GROUP INC9,242,43709,242,43744,456,122Neu+100,0%
STATE STREET CORP5,908,21105,908,21128,418,495Neu+100,0%
ADAR1 Capital Management, LLC5,415,10905,415,10926,046,674Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC3,677,30703,677,30717,691,051Neu+100,0%
BlackBarn Capital Partners LP1,850,00001,850,0008,898,500Neu+100,0%
BANK OF AMERICA CORP /DE/1,832,70401,832,7048,815,305Neu+100,0%
Rubric Capital Management LP1,575,37601,575,3767,577,559Neu+100,0%
CITIGROUP INC1,570,34901,570,3497,553,378Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,562,26501,562,2657,514,495Neu+100,0%
OSAIC HOLDINGS, INC.1,348,22401,348,2246,484,957Neu+100,0%
NORTHERN TRUST CORP1,236,68901,236,6895,948,475Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC890,8980890,8984,285,220Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP775,2110775,2113,728,765Neu+100,0%
BANK OF MONTREAL /CAN/766,6560766,6563,687,615Neu+100,0%
GOLDMAN SACHS GROUP INC738,5800738,5803,552,570Neu+100,0%
Hudson Bay Capital Management LP675,0000675,0003,246,750Neu+100,0%
Quinn Opportunity Partners LLC514,5130514,5132,474,808Neu+100,0%
KENNEDY CAPITAL MANAGEMENT LLC505,0940505,0942,429,502Neu+100,0%
Murchinson Ltd.497,9000497,9002,394,899Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP474,3610474,3612,281,676Neu+100,0%
BARCLAYS PLC356,6840356,6841,715,650Neu+100,0%
Saba Capital Management, L.P.347,8850347,8851,673,327Neu+100,0%
Swiss National Bank283,4000283,4001,363,154Neu+100,0%
Ledgewood Wealth Advisors, LLC278,4360278,4361,339,277Neu+100,0%
Invesco Ltd.247,2540247,2541,189,292Neu+100,0%
D. E. Shaw & Co., Inc.231,7630231,7631,114,780Neu+100,0%
Caption Management, LLC200,0000200,000962,000Neu+100,0%
RHUMBLINE ADVISERS183,2500183,250881,423Neu+100,0%
SIMPLEX TRADING, LLC182,0030182,003875,434Neu+100,0%
WELLS FARGO & COMPANY/MN167,0210167,021803,371Neu+100,0%
Qube Research & Technologies Ltd157,5780157,578757,950Neu+100,0%
GROUP ONE TRADING LLC153,0160153,016736,007Neu+100,0%
CITADEL ADVISORS LLC149,3430149,343718,340Neu+100,0%
UBS Group AG147,2920147,292708,475Neu+100,0%
JANE STREET GROUP, LLC145,2330145,233698,571Neu+100,0%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM144,1100144,110693,169Neu+100,0%
ALLIANCEBERNSTEIN L.P.143,8700143,870692,015Neu+100,0%
DEUTSCHE BANK AG\140,1980140,198674,352Neu+100,0%
BOOTHBAY FUND MANAGEMENT, LLC136,9240136,924658,604Neu+100,0%
FMR LLC136,5560136,556656,834Neu+100,0%
Legal & General Group Plc122,7610122,761590,480Neu+100,0%
Man Group plc120,8210120,821581,149Neu+100,0%
JPMORGAN CHASE & CO97,875097,875470,779Neu+100,0%
STATE OF WISCONSIN INVESTMENT BOARD92,769092,769446,219Neu+100,0%
SIG BROKERAGE, LP81,900081,900393,939Neu+100,0%
EntryPoint Capital, LLC75,607075,607363,670Neu+100,0%
MetLife Investment Management, LLC73,236073,236352,265Neu+100,0%
INTECH INVESTMENT MANAGEMENT LLC70,563070,563339,408Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-3124.1424,30103.811
2026-03-275184,452.305
2026-03-26100.0954,53453.430
2026-03-251484,31638
2026-03-183.2394,3614.122
2026-03-1664,2626
2026-03-121004,72472
2026-03-091294,53584
2026-02-18199.9304,17833.708

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
MORGAN STANLEY26,702,776128,440,35330.63
BlackRock, Inc.13,052,86162,784,26114.97
VANGUARD GROUP INC9,242,43744,456,12210.60
STATE STREET CORP5,908,21128,418,4956.78
ADAR1 Capital Management, LLC5,415,10926,046,6746.21
GEODE CAPITAL MANAGEMENT, LLC3,677,30717,691,0514.22
BlackBarn Capital Partners LP1,850,0008,898,5002.12
BANK OF AMERICA CORP /DE/1,832,7048,815,3052.10
Rubric Capital Management LP1,575,3767,577,5591.81
CITIGROUP INC1,570,3497,553,3781.80
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,562,2657,514,4951.79
OSAIC HOLDINGS, INC.1,348,2246,484,9571.55
NORTHERN TRUST CORP1,236,6895,948,4751.42
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC890,8984,285,2201.02
SUSQUEHANNA INTERNATIONAL GROUP, LLP775,2113,728,7650.89
BANK OF MONTREAL /CAN/766,6563,687,6150.88
GOLDMAN SACHS GROUP INC738,5803,552,5700.85
Hudson Bay Capital Management LP675,0003,246,7500.77
Quinn Opportunity Partners LLC514,5132,474,8080.59
KENNEDY CAPITAL MANAGEMENT LLC505,0942,429,5020.58

Hinweis

Erweitert ×